Work with thought leaders and academic experts in nephrology

Companies can greatly benefit from working with experts in the field of nephrology. These researchers bring a deep understanding of kidney diseases, treatments, and advancements. By collaborating with nephrology thought leaders, companies can enhance their research and development efforts, gain valuable insights into the latest trends and technologies, and accelerate innovation in the field. Whether it's developing new drugs, medical devices, or treatment protocols, partnering with nephrology experts can lead to breakthrough discoveries and improved patient outcomes.

Experts on NotedSource with backgrounds in nephrology include Luke Connelly, Charles T. Hill, PhD, Mehrdad Sheikhvatan, and Bryan L Williams.

Luke Connelly

Professor of Health Economics, The University of Queensland, CBEH
Most Relevant Research Interests
Other Research Interests (52)
Health economics
Public Health, Environmental and Occupational Health
Safety, Risk, Reliability and Quality
Human Factors and Ergonomics
And 47 more
Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link]( process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.
Most Relevant Publications (1+)

105 total publications

Geriatric CKD: Value-Based Nephrology

Advances in Chronic Kidney Disease / Jan 01, 2016

Yee, J. (2016). Geriatric CKD: Value-Based Nephrology. Advances in Chronic Kidney Disease, 23(1), 1–5.

Mehrdad Sheikhvatan

Iran University of Medical Sciences
Most Relevant Research Interests
Other Research Interests (58)
Molecular Cardiogenetic
Obstetrics and Gynecology
Neurology (clinical)
And 53 more
Most Relevant Publications (1+)

90 total publications

The value of N-terminal pro-B-type natriuretic peptide (NT Pro-BNP) to predict sudden cardiac death in chronic heart failure patients with normal renal function; a systematic review and meta-analysis

Journal of Nephropharmacology / Jul 27, 2018

Sheikhvatan, M., Ataei, Z., Heydari, A., & Zahergivar, A. (2018). The value of N-terminal pro-B-type natriuretic peptide (NT Pro-BNP) to predict sudden cardiac death in chronic heart failure patients with normal renal function; a systematic review and meta-analysis. Journal of Nephropharmacology, 7(2), 164–168.

Example nephrology projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on nephrology?

Drug Development for Kidney Diseases

A pharmaceutical company can collaborate with a nephrology researcher to develop new drugs for kidney diseases. The researcher's expertise in understanding the underlying mechanisms of kidney diseases and their experience in conducting clinical trials can greatly contribute to the development of effective and safe medications.

Medical Device Innovation

A medical device company can partner with a nephrology expert to innovate and improve devices used in dialysis treatments. The researcher's knowledge of dialysis procedures and patient needs can help in designing more efficient and user-friendly devices, leading to better treatment outcomes and enhanced patient experience.

Precision Medicine in Nephrology

A biotech company can collaborate with a nephrology researcher to develop personalized treatment approaches for kidney diseases. By analyzing genetic and molecular data, the researcher can identify biomarkers and genetic variants that influence disease progression and response to treatment, enabling the development of targeted therapies for individual patients.

Telemedicine Solutions for Nephrology

A healthcare technology company can work with a nephrology expert to develop telemedicine solutions for remote monitoring and management of kidney diseases. The researcher's understanding of the unique challenges faced by nephrology patients and their expertise in leveraging technology can help in creating user-friendly platforms that improve access to care and enable timely interventions.

Clinical Trials and Research Collaborations

Companies involved in clinical research can collaborate with nephrology researchers to conduct clinical trials and studies related to kidney diseases. The researcher's knowledge of disease mechanisms, patient populations, and research methodologies can contribute to the successful execution of trials, leading to the development of evidence-based treatments and therapies.